Neuren Pharmaceuticals Future Growth
Future criteria checks 3/6
Neuren Pharmaceuticals is forecast to grow earnings and revenue by 5.2% and 13.5% per annum respectively. EPS is expected to grow by 4.9% per annum. Return on equity is forecast to be 34.6% in 3 years.
Key information
5.2%
Earnings growth rate
4.9%
EPS growth rate
Pharmaceuticals earnings growth | 27.3% |
Revenue growth rate | 13.5% |
Future return on equity | 34.6% |
Analyst coverage | Low |
Last updated | 04 Mar 2024 |
Recent future growth updates
Recent updates
Forecast: Analysts Think Neuren Pharmaceuticals Limited's (ASX:NEU) Business Prospects Have Improved Drastically
Mar 05Here's Why Neuren Pharmaceuticals (ASX:NEU) Has Caught The Eye Of Investors
Mar 02Neuren Pharmaceuticals Limited's (ASX:NEU) 51% Jump Shows Its Popularity With Investors
Dec 18Need To Know: Analysts Are Much More Bullish On Neuren Pharmaceuticals Limited (ASX:NEU) Revenues
Sep 02Calculating The Fair Value Of Neuren Pharmaceuticals Limited (ASX:NEU)
Aug 31This Just In: Analysts Are Boosting Their Neuren Pharmaceuticals Limited (ASX:NEU) Outlook for This Year
Mar 03Neuren Pharmaceuticals (ASX:NEU) Is In A Strong Position To Grow Its Business
Jan 07We Think Neuren Pharmaceuticals (ASX:NEU) Can Easily Afford To Drive Business Growth
Sep 06Companies Like Neuren Pharmaceuticals (ASX:NEU) Can Afford To Invest In Growth
May 31We're Not Worried About Neuren Pharmaceuticals' (ASX:NEU) Cash Burn
Feb 03Here's Why We're Not At All Concerned With Neuren Pharmaceuticals' (ASX:NEU) Cash Burn Situation
Aug 06We Think Neuren Pharmaceuticals (ASX:NEU) Can Easily Afford To Drive Business Growth
May 05Independent Non-Executive Chairman Patrick Donald Davies Just Bought 21% More Shares In Neuren Pharmaceuticals Limited (ASX:NEU)
Feb 19Have Insiders Been Selling Neuren Pharmaceuticals Limited (ASX:NEU) Shares This Year?
Jan 04Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 319 | 189 | 180 | 165 | 5 |
12/31/2025 | 174 | 96 | 127 | 122 | 5 |
12/31/2024 | 154 | 93 | 76 | 87 | 5 |
12/31/2023 | 232 | 157 | 185 | 185 | N/A |
9/30/2023 | 155 | 106 | 120 | 120 | N/A |
6/30/2023 | 78 | 55 | 54 | 54 | N/A |
3/31/2023 | 47 | 28 | 29 | 29 | N/A |
12/31/2022 | 15 | 0 | 4 | 4 | N/A |
9/30/2022 | 9 | -3 | -3 | -3 | N/A |
6/30/2022 | 3 | -7 | -10 | -10 | N/A |
3/31/2022 | 3 | -7 | -10 | -10 | N/A |
12/31/2021 | 3 | -8 | -10 | -10 | N/A |
9/30/2021 | 2 | -10 | -10 | -10 | N/A |
6/30/2021 | 1 | -12 | -9 | -9 | N/A |
3/31/2021 | 1 | -11 | -9 | -9 | N/A |
12/31/2020 | 1 | -9 | -8 | -8 | N/A |
9/30/2020 | 1 | -8 | -9 | -9 | N/A |
6/30/2020 | 0 | -8 | -9 | -9 | N/A |
3/31/2020 | 0 | -9 | -10 | -10 | N/A |
12/31/2019 | 0 | -11 | -12 | -12 | N/A |
9/30/2019 | 7 | -6 | -5 | -5 | N/A |
6/30/2019 | 14 | -1 | 2 | 2 | N/A |
3/31/2019 | 14 | 1 | 4 | 4 | N/A |
12/31/2018 | 14 | 3 | 6 | 6 | N/A |
9/30/2018 | 7 | 3 | 0 | 0 | N/A |
6/30/2018 | 1 | 3 | -6 | -6 | N/A |
3/31/2018 | 1 | 3 | -6 | -6 | N/A |
12/31/2017 | 1 | 3 | -6 | -6 | N/A |
9/30/2017 | 2 | -2 | N/A | -7 | N/A |
6/30/2017 | 3 | -8 | N/A | -8 | N/A |
3/31/2017 | 3 | -10 | N/A | -10 | N/A |
12/31/2016 | 3 | -12 | N/A | -12 | N/A |
9/30/2016 | 2 | -14 | N/A | -14 | N/A |
6/30/2016 | 0 | -15 | N/A | -17 | N/A |
3/31/2016 | 1 | -14 | N/A | -15 | N/A |
12/31/2015 | 2 | -13 | N/A | -13 | N/A |
9/30/2015 | 2 | -11 | N/A | -11 | N/A |
6/30/2015 | 3 | -9 | N/A | -8 | N/A |
3/31/2015 | 3 | -9 | N/A | -7 | N/A |
12/31/2014 | 3 | -8 | N/A | -6 | N/A |
9/30/2014 | 3 | -10 | N/A | -7 | N/A |
6/30/2014 | 3 | -12 | N/A | -7 | N/A |
3/31/2014 | 4 | -11 | N/A | -7 | N/A |
12/31/2013 | 5 | -10 | N/A | -7 | N/A |
9/30/2013 | 5 | -9 | N/A | -7 | N/A |
6/30/2013 | 5 | -6 | N/A | -5 | N/A |
3/31/2013 | 5 | -5 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NEU's forecast earnings growth (5.2% per year) is above the savings rate (2.2%).
Earnings vs Market: NEU's earnings (5.2% per year) are forecast to grow slower than the Australian market (13% per year).
High Growth Earnings: NEU's earnings are forecast to grow, but not significantly.
Revenue vs Market: NEU's revenue (13.5% per year) is forecast to grow faster than the Australian market (4.8% per year).
High Growth Revenue: NEU's revenue (13.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NEU's Return on Equity is forecast to be high in 3 years time (34.6%)